EGFR and head and neck squamous cell carcinoma: Among the 4 murine HNSCC cell lines tested, B4B8 [37] is dependent on EGFR/ERBB signaling for growth as assessed by sensitivity to the pan-ERBB inhibitor, AZD8931, and the specific EGFR inhibitor, gefitinib (Additional file 1: Fig. S3).